Stockreport
Sources: White House ordered firing of L.A. federal prosecutor on ex-Fatburger CEO case [Los Angeles Times (CA)]
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
pushed officials in Washington to drop all charges against him, according to multiple sources familiar with the matter. Adam Schleifer was terminated Friday morning, receiving an email informing him that the dismissal was “on behalf of President Donald J. Trump,” according to two of the sources, who requested anonymity for fear of reprisals from federal officials. Joseph T. McNally, the acting U.S. attorney for the Central District of California who is Schleifer's boss, was not involved in the decision, the sources said. Carley Palmer, a former federal prosecutor in Los Angeles who is now a partner at Halpern May Ybarra Gelberg LLP, said she heard Schleifer was fired via a “one line e-mail, and it came from a White House staff account.” A spokesperson for the U.S. attorney's office in Los Angeles declined to comment. Schleifer declined a request to be interviewed. The White House and the U.S. Department Of Justice did not immediately respond to inquiries. The sources who spoke
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | REGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
REGN alerts
REGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
REGN alerts
High impacting Regeneron Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
REGN
NEWS
NEWS
- Regeneron (REGN) Is Up 5.4% After New Myeloma Data And Gene Writing Tie-Up With Tessera [Yahoo! Finance][Yahoo! Finance]
- 2 Reasons to Buy Regeneron Stock Like There's No Tomorrow [Yahoo! Finance][Yahoo! Finance]
- Regeneron Pharmaceuticals (NASDAQ:REGN) had its price target raised by analysts at Morgan Stanley from $767.00 to $768.00. They now have an "equal weight" rating on the stock.[MarketBeat]
- Biohaven jumps on early-stage data for antibody drug conjugate combo [Seeking Alpha][Seeking Alpha]
- 3 Low-Volatility Stocks We're Skeptical Of [Yahoo! Finance][Yahoo! Finance]
- More
REGN
SEC Filings
SEC Filings
- 12/11/25 - Form 4
- 12/11/25 - Form 4
- 12/11/25 - Form 4
- REGN's page on the SEC website
- More